Acute Coronary Syndrome

CVD and depression are a two-way street, capable of inflicting considerable damage on one another. So how do heart patients protect their mental health after a life-threatening event like MI?

Despite a sizable financial disadvantage, ST-segment elevation MI (STEMI) patients who could be treated effectively in an intensive or non-intensive care unit fare better in the ICU, according to research published June 4 in The BMJ.

Researchers at Imperial College London have developed a sew-on heart patch that leverages stem cells to support and repair heart muscle after a heart attack—something that could dramatically lower MI survivors’ risk of future heart failure.

Researchers have identified a new barrier to timely care for MI patients: a perceived inability to act that leaves them immobilized and unable to seek professional help, in some cases for an excess of 24 hours.

An undocumented immigrant living in Brooklyn, N.Y., was deported to his home country last Wednesday after ICE officials ignored attorneys’ requests to keep him in the U.S. for much-needed medical treatment, WNYC reported.

Mental health disorders like PTSD and depression might not be as much of a barrier to cardiac rehabilitation as was previously thought, according to a study of more than 85,000 U.S. veterans published in the Journal of the American Heart Association.

Bypassing standard angiography and skipping straight to an MRI might help physicians more easily identify and treat patients who have suffered non-ST segment elevation myocardial infarction (NSTEMI), a team at Weill Cornell Medicine and NewYork-Presbyterian have found.

An expert consensus document endorsed by four major cardiology societies redefines cardiogenic shock based on patient descriptions, physical markers and a standardized set of vocabulary.

Researchers say such misnomers could have major policy implications, especially in an increasingly value-based landscape.

Low-dose daily aspirin may be effective as a preventive therapy for heart patients with symptomatic atherosclerotic disease, but in the general population the drug’s risk of intracranial bleeding outweighs any CV benefits it may have, according to a study published May 13 in JAMA Neurology.

CVD-related fatalities in individuals under 75 years old are on the rise in the U.K. for the first time in five decades, the Guardian reported May 12.

A machine learning algorithm can now predict death and MI more accurately than certified cardiologists, according to research presented at the International Conference on Nuclear Cardiology and Cardiac CT in Lisbon, Portugal, this May.